Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Inflammation × Exercise × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Endocrine 1 Breast 1

Conditions

Breast Neoplasms 110 Motor Activity 57 Obesity 8 Neoplasms 7 Lymphedema 7 Fatigue 7 Colorectal Neoplasms 6 Prostatic Neoplasms 5 Cardiotoxicity 5 Breast Cancer Lymphedema 5 Weight Loss 4 Ovarian Neoplasms 3 Breast Cancer Female 3 Recurrence 2 Overweight 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Lung Neoplasms 2 Breast Diseases 2 Atherosclerosis 2 Arthralgia 2 Ventricular Dysfunction, Left 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urogenital Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Risk Reduction Behavior 1 Post-operative Breast Cancer 1 Peripheral Vascular Diseases 1

Interventions

palbociclib 2 Ketorolac 2 dapagliflozin 1 Tablets 1 Surgical Procedures, Operative 1 Sulindac 1 Specimen Handling 1 Rivaroxaban 1 Resistance Training 1 Radiotherapy, Conformal 1 Pregabalin 1 Plastic Surgery Procedures 1 Omeprazole 1 Neoadjuvant Therapy 1 Mastectomy 1 Massage 1 Losartan 1 Ibuprofen 1 Fish Oils 1 Exercise 1 Cognitive Behavioral Therapy 1 Bevacizumab 1 Anti-Inflammatory Agents, Non-Steroidal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01147367 2016-03-08

ABLE

University of Alabama at Birmingham

Phase NA Completed

Breast Neoplasms, Fatigue, Inflammation, Motor Activity, Parasomnias

Data powered by HemOnc (CC BY 4.0) Colophon ⚡